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ABSTRACT
hnRNPA2 is a major component of mRNA transport
granules in oligodendrocytes and neurons. However,
the structural details of how hnRNPA2 binds the
A2 recognition element (A2RE) and if this sequence
stimulates granule formation by enhancing phase
separation of hnRNPA2 has not yet been studied. Us-
ing solution NMR and biophysical studies, we find
that each of the two individual RRMs retain the do-
main structure observed in complex with RNA but are
not rigidly confined (i.e. they move independently) in
solution in the absence of RNA. hnRNPA2 RRMs bind
the minimal rA2RE11 weakly but at least, and most
likely, two hnRNPA2 molecules are able to simulta-
neously bind the longer 21mer myelin basic protein
A2RE. Upon binding of the RNA, NMR chemical shift
deviations are observed in both RRMs, suggesting
both play a role in binding the A2RE11. Interestingly,
addition of short A2RE RNAs or longer RNAs con-
taining this sequence completely prevents in vitro
phase separation of full-length hnRNPA2 and ag-
gregation of the disease-associated mutants. These
findings suggest that RRM interactions with specific
recognition sequences alone do not account for nu-
cleating granule formation, consistent with models
where multivalent protein:RNA and protein:protein
contacts form across many sites in granule proteins
and long RNA transcripts.
INTRODUCTION
Spatial and temporal control of mRNA translation is cru-
cial for highly coordinated biological processes like devel-
opment and synaptic plasticity. RNA-binding proteins play
a major role in regulating translation (1). The RNA-binding
protein heterogeneous nuclear ribonucleoprotein (hnRNP)
A2 is a well-studied component of granules that move
mRNA from the nucleus to sites of local translation (2).
hnRNPA2-containing granules were first studied in oligo-
dendrocytes, where hnRNPA2 binds myelin basic protein
mRNA and transports it to the oligodendroglial processes
for local translation (3). hnRNPA2 binds a cis-acting ele-
ment in myelin basic protein mRNA called the A2 response
element (A2RE) in the 3′ untranslated region (3–5). The
myelin basic protein mRNA consists of a 21-nucleotide se-
quence encoding two overlapping tandem A2REs of 11 nu-
cleotides each (5,6). Similar, but not identical A2REs that
bind hnRNPA2 have been identified in other transcripts,
including mRNAs encoding ARC, neurogranin, alpha cal-
cium calmodulin-dependent protein kinase II (CaMKII),
tau, and brain derived neurotrophic factor (BDNF) (7–9),
demonstrating that hnRNPA2 has the ability to bind a vari-
ety of sequences. These transcripts are transported in trans-
port granules containing mRNA, hnRNPA2 and other pro-
teins (2). While we know the identity of many of these gran-
ule components, the architecture and interactions holding
the granules together are unclear. At the same time, the dis-
covery that hnRNPA2 can undergo liquid–liquid phase sep-
aration (LLPS) (10) has provided a model for how granules
are formed, yet it is not clear how the presence of RNA af-
fects these interactions. Some evidence suggests that RNA
nucleates stress granule formation, but it is not clear if this
is true of transport granules (11–13).
The structural basis of hnRNPA2 binding the A2RE
is unclear. Recent work on the highly related protein hn-
RNPA1 showed that both tandem RNA recognition mo-
tifs (RRM) are required to bind the non-A2RE-like in-
tronic splicing silencer at exon 7 (ISS-N1) of survival of
motor neuron mRNA (14). The second RRM binds the 5′
region of the RNA studied and the RNA wraps around
the RRMs, which sit almost back-to-back with substan-
tial interacting surface area (14). In contrast, recent crystal
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structures (5EN1, 5HO4) of hnRNPA2 RRMs binding 8
or 10 nucleotide RNA sequences found that two hnRNPA2
molecules each consisting of 2 RRMs were required to
bind two RNA molecules (15). Wu et al. found that RRM1
bound the 5′ region of the RNA and the RNA was stretched
across two molecules of hnRNPA2, binding one RRM from
each molecule of hnRNPA2 (15). Despite these different
RNA arrangements, crystal structures of the related protein
hnRNPA1 have RRM1 and RRM2 arranged in a similar
configurations (<2 Å RMSD) (16–18). Further, recent work
on hnRNPA1 RRMs binding a microRNA indicated 1:1
stoichiometry in solution experiments but a 2:2 stoichiom-
etry in the crystal structure (18). Given the high identity
of hnRNPA2 and hnRNPA1, as well as similar 2:2 crystal
structures of hnRNPA1 (18,19) with 1:1 solution structures
of hnRNPA1 (14,18), it seems possible that the proposed
two protein to two RNA molecule stoichiometry of the hn-
RNPA2 crystal structure is the result of crystal packing con-
tacts. Additionally, the RNA sequences studied are reason-
ably different from the A2RE, both in length and sequence,
so hnRNPA2 may interact with the A2RE differently than
these sequences. Hence, it is important to understand how
hnRNPA2 interacts with the A2RE in solution in order to
understand hnRNPA2 function.
Additionally, a number of RNA-binding proteins are
known to be involved in neurodegenerative disease, in par-
ticular amyotrophic lateral sclerosis and frontotemporal de-
mentia (ALS/FTD) (20). One hypothesis to explain the
enrichment of RNA-binding proteins in genes mutated in
ALS or FTD relates to the ability of many RNA binding
proteins to undergo liquid–liquid phase separation (LLPS),
forming protein-dense assemblies that may convert to pro-
tein aggregates in disease (21). LLPS is a phenomenon
where proteins and nucleic acids demix from the surround-
ing solution to form a liquid phase distinct from the sur-
rounding cytoplasm/nucleoplasm (in vivo) or buffer (in
vitro). hnRNPA2 is capable of LLPS in vitro (10), but the
effect of RNA binding on hnRNPA2 LLPS is unknown.
hnRNPA2 is mutated in multisystem proteinopathy (MSP),
a disease with elements of ALS and FTD as well as muscle
and bone degeneration (22) and Paget’s disease of bone (23).
These disease mutations (D290V and P298L, respectively)
are located in the disordered domain C-terminal to RRMs
and cause hnRNPA2 to aggregate in vitro (10), but the ef-
fect of RNA on this process is unknown. Here, we use so-
lution NMR and biophysical assays to determine the struc-
ture of the hnRNPA2 RRMs, how they bind to the A2RE,
and how A2RE-binding affects phase separation and ag-
gregation of full length hnRNPA2. These studies add to the
structural information on hnRNPA2 and demonstrate that
weak binding to RNA-binding proteins can prevent LLPS.
MATERIALS AND METHODS
Constructs
The following constructs and general purification strategies
were used for protein expression in BL21 Star (DE3) Es-
cherichia coli cultures (Life Technologies):
• hnRNPA2 1–189, soluble histag purification (Addgene
ID: 157864)
• hnRNPA2 RRM1 (1–93), soluble histag purification
(Addgene ID: 157865)
• hnRNPA2 RRM2 (94–189), soluble histag purification
(Addgene ID: 157866)
• hnRNPA2 LC (190–341), insoluble histag purification
(Addgene ID: 98657)
• C-terminal maltose binding protein tagged hnRNPA2
FL WT, D290V and P298L, soluble histag purification
(Addgene ID: 139109, 139110, 139111 respectively).
Bacterial culture and isotope labeling
Uniformly 15N- or 13C-labeled proteins were expressed in
M9 in H2O with 15N ammonium chloride as the sole ni-
trogen source or 13C-glucose as the sole carbon source as
appropriate. Unlabeled proteins were expressed in LB. Cell
pellets were harvested from 1 l cultures induced with IPTG
at an OD600 of 0.6–1 after 4 h at 37◦C. Pellets were resus-
pended in 20 mM NaPi pH 7.4, 1 M NaCl, 10 mM imida-
zole (∼30 ml per pellet from 1 liter culture) with a Roche
Complete EDTA-free protease inhibitor tablet or a Pierce
protease inhibitor tablet. Resuspended pellets were lysed on
an Emulsiflex C3 and the cell lysate cleared by centrifuga-
tion (20 000 × g for 60 min at 4◦C).
Purification
Cleared RRM lysate was filtered and loaded onto a HisTrap
5 ml column. Protein was eluted in a gradient of 10–300
mM imidazole over five column volumes. Fractions con-
taining hnRNPA2 RRM was pooled and buffer exchanged
to reduce imidazole concentration to <50 mM. Protein was
incubated with TEV protease overnight at room tempera-
ture. After TEV cleavage, protein was loaded onto a 5 ml
HisTrap column and flow through containing cleaved hn-
RNPA2 RRM was pooled, concentrated, and loaded onto
a Superdex 75 column equilibrated in 20 mM NaPi pH 7.4
1 M NaCl. Fractions containing undegraded protein were
pooled, concentrated, and flash frozen. Protein was effec-
tively free of nucleic acid contamination as A260/A280 UV
absorbance ratios were 0.55–0.60.
Cleared full-length hnRNPA2-MBP lysate was filtered
and loaded onto a HisTrap 5 ml column. Protein was eluted
in a gradient of 10–300 mM imidazole over five column vol-
umes. Fractions containing hnRNPA2-MBP were pooled
and loaded onto a Superdex 200 equilibrated in 20 mM
NaPi pH 7.4 1 M NaCl. Fractions containing full length
protein without degradation products were pooled and pro-
tein was concentrated to ∼1 mM and flash frozen. Protein
was effectively free of nucleic acid contamination as deter-
mined by A260/A280 ratios of 0.5–0.6.
hnRNPA2 LC was purified as described (10). Briefly, the
insoluble pellet was resuspended in 8 M urea, cleared, fil-
tered, and loaded onto a 5 ml HisTrap column. Protein
was eluted in a gradient of 10–300 mM imidazole over five
column volumes. Pooled fractions containing protein were
buffer exchanged into 8 M urea pH 5.5 20 mM MES di-
luted with 20 mM MES pH 5.5 to a final urea concentra-
tion of 500–1000 mM, and incubated with TEV overnight.
Cleaved protein was solubilized in 8 M urea, loaded onto
the HisTrap column and flow through containing cleaved
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hnRNPA2 LC was pooled, concentrated, buffer exchanged
into 8 M urea pH 5.5 20 mM MES and flash frozen.
RNA and DNA
RNA was ordered from Horizon Discovery (formerly
Dharmacon, https://horizondiscovery.com/products/
tools/Order-Single-strand-RNA) with HPLC purifica-
tion and 2′ deprotected and desalted by the company.
The sequences are: rA2RE11 GCCAAGGAGCC,
rA2RE21 GCCAAGGAGCCAGAGAGCAUG,
rA2RE21scr GGACGACAGGACGCGAGCUAA,
Cy3-rA2RE11 Cy3- GCCAAGGAGCC, Wu 10mer
AAGGACUAGC, long rA2RE21 UGCGGAUAGACA
GGCACACCGCCAAGGAGCCAGAGAGCAUGG
CGCAGGGGACUGUGUGGU, and long rA2RE21scr
UGCGGAUAGACAGGCACACCGGACGACAGG
ACGCGAGCUAAGCGCAGGGGACUGUGUGGU.
DNA was ordered from Invitrogen.
ITC
Isothermal titration calorimetry (ITC) experiments
were performed on a VP-ITC instrument (MicroCal
Inc/Malvern). Absorbance at 280 and 260 nm was used to
determine the concentrations of proteins and RNAs, re-
spectively. Sample concentrations were estimated using the
extinction coefficients calculated by ProtParam. Samples
were prepared in 20 mM NaPi pH 6.75, 150 mM NaCl; 20
mM KPi pH 6.75; or 20 mM MES pH 6.7, 150 mM NaCl,
10 mM CaCl2 as appropriate. Samples were degassed for
15 min prior to titration using a Thermovac (MicroCal
Inc./Malvern). The measurements were performed using
the protein as titrant (syringe) and the RNA as titrand
(cell). All measurements were performed at a cell tempera-
ture of 25◦C over at least 27 injections starting with at least
one 2 l initial injection (as indicated where additional 2
l initial injections were added). All other injections were
10 l. Spacing time was 240 s for most runs except the
experiment in the CaCl2 buffer, where it was 300 s. The
filter period was 2 s and stir speed was 307 rpm for all runs.
The reference power was set to 30 cal/s and the initial
delay to 60 s. The data was analyzed using Origin version
7.0 (MicroCal Inc). For A2RE11 and the Wu 10mer, a
binding model using nonlinear least-squares fitting and
one binding site was applied.
Phase separation/aggregation
Samples of full-length hnRNPA2-MBP were prepared for
microscopy by diluting proteins from 1 M NaCl buffer to
final protein and salt concentrations. Solid RNA was dis-
solved in the volume of 20 mM Tris pH 7.5 calculated to
give 1 mM RNA concentration based on the RNA weight
on the tube. Final RNA concentration was determined by
absorbance at 260 nm using NanoDrop and the given ex-
tinction coefficient for the RNA oligomer. 50 l samples of
15 M protein in 20 mM Tris pH 7.5, with a final NaCl con-
centration of 50 or 150 mM as appropriate were prepared
for each time point. TEV was added and allowed to cleave
for indicated time. 20 l of sample was spotted onto a cov-
erslip and the water drop imaged. DIC images were taken
with an Axiovert 200M microscope (Zeiss). Phase separa-
tion experiments with hnRNPA2 LC were performed as in
(10) with the addition of fluorescently labeled RNA at given
concentrations dissolved in pH 5.5 20 mM MES.
NMR
Solution NMR samples. hnRNPA2 1–189 NMR samples
were made by diluting protein from stocks containing 1 M
NaCl into 20 mM NaPi pH 6.8 with 10% 2H2O to a final salt
concentration of 150 mM. Sample concentrations were es-
timated using the extinction coefficients calculated by Prot-
Param.
Solution NMR experiments. NMR experiments were
recorded at 298 or 310 K as indicated using a Bruker Avance
NMR spectrometer operating at 850 MHz 1H frequency or
500 MHz 1H frequency as indicated. Experimental sweep
widths, acquisition times, and the number of transients were
optimized for the necessary resolution, experiment time and
signal to noise for each experiment type.
hnRNPA2 1–189 Assignments. Triple resonance as-
signment experiments were performed on samples of
13C/15N uniformly labeled hnRNPA2 1–189 (condi-
tions: 20 mM NaPi pH 6.8 150 mM NaCl with 10%
2H2O). CBCA(CO)NH, HNCACB, HNCA, HCNO and
HN(CA)CO were recorded with sweep widths 16 ppm
(center 4.7) in 1H, 34.5 ppm (center 116) in 15N, 14 ppm
(center 176) in 13C for CO experiments and 61 ppm (center
43) in 13C for CA/CB experiments using standard Bruker
Topspin3.5 pulse programs with default parameter sets
(cbcaconhgp3d, hncacbgp3d, hncagp3d, hncacogp3d,
hncogp3d). Experiments comprised 68, 64, 56 and 1536
points in the indirect 15N, indirect 13C/C, indirect 13CO
and direct 1H dimensions respectively.
NMR chemical shift deviations. 1H–15N HSQCs of 200 hn-
RNPA2 1–189 with indicated ratios of RNA were acquired
at 850 MHz 1H Larmor frequency or 500 MHz 1H Larmor
frequency with 256* and 1536* complex pairs in the indi-
rect 15N and direct 1H dimensions with corresponding ac-
quisition times of 33 ms and 57 ms and sweep widths of 45
and 16 ppm centered at 116 and 4.7, respectively. 15N and
1H chemical shifts were measured from the cross peaks on
the HSQCs for the given mixture of components. Chemical
shift deviations for 1H and 15N were quantified by subtract-
ing the chemical shift of the reference spectrum (1:0 sam-
ple for titrations) from the respective value of each other
sample (for the individual RRMs compared to 1–189, 1–
189 was the reference spectrum). The average chemical shift
deviations were calculated by the equation: δ(15N, 1H) =√
1
2 (δH
2 + (0.14δN)2).
Relaxation. Motions of the backbone of hnRNPA2 1–189
were probed using 15N R1, temperature-compensated 15N
R2, and heteronuclear NOE experiments using standard
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pulse sequences (hsqct1etf3gpsitc3d, hsqct2etf3gpsitc3d,
hsqcnoef3gpsi, respectively, from Topspin 3.5, Bruker). In-
terleaved experiments comprised 256 × 1536 total points in
the indirect 15N and direct 1H dimensions, respectively, with
corresponding acquisition times of 33 and 57 ms, sweep
width of 45 and 16 ppm, centered at 116 and 4.7 ppm, re-
spectively. 15N R2 experiments had an interscan delay of 2.5
s, a Carr-Purcell-Meiboom-Gill (CPMG) field of 556 Hz,
and total R2 relaxation CMPG loop-lengths of 16.5, 148.5,
115.5, 33, 66, 82.5 and 49.5 ms at 850 MHz 1H frequency
and 16.5, 247.5, 115.5, 33, 148.5, 66 and 198 ms at 500 MHz
1H frequency. 15N R1 experiments had an interscan delay
of 1.2 s at 850 MHz 1H frequency and 1.5 s at 500 MHz
1H frequency, and total R1 relaxation loop-lengths of 100,
1500, 200, 800, 1200, 600 and 400 ms at 850 MHz 1H fre-
quency and 100, 1200, 200, 800, 300, 600 and 400 ms at 500
MHz 1H frequency. Heteronuclear NOE experiments were
conducted with an interscan delay of 7 s at 850 MHz 1H
frequency and 5 s at 500 MHz 1H frequency.  c was cal-
culated by averaging the T1 and T2 from each residue for
the apo and bound form. These values were then used in
the equation τc = 14πνN
√
6 T1T2 − 7 where νN is the 15N res-
onance frequency in Hz. Predicted τ c was calculated using
http://nickanthis.com/tools/tau (empirical formula).
Residual dipolar coupling. Backbone amide (1DNH) RDCs
for well resolved 1H–15N cross-peaks were measured on
samples of weakly aligned hnRNPA2 1–189 in a dilute
liquid crystalline medium of PEG-hexanol at 850 1H
MHz frequency at 298 K using a standard pulse sequence
(hsqcf3gpiaphwg.2 from TopSpin 3.5, Bruker). Samples
consisted of 200 M hnRNPA2 1–189 in 20 mM NaPi pH
6.8 150 mM NaCl with 10% D2O in PEG-hexanol (4%
PEG by weight) with an r value of 0.96 (mol PEG/mol
hexanol). Interleaved experiments comprised of 384 × 2048
total points in the indirect 15N and direct 1H dimensions,
respectively, with corresponding acquisition times of 131
ms and 86 ms, sweep width of 34 and 14 ppm, centered
at 116 and 4.7 ppm, respectively. To avoid structural noise
from flexible regions, only the backbone amides from sec-
ondary structure elements were included in the analysis.
Singular value decomposition of the experimental 1DNH
RDCs were fit to the coordinates of the isolated RRM1 and
RRM2 of the 5HO4 crystal structure of hnRNPA2 RRMs
as well as the full length tandem RRMs (15).
RESULTS
Apo hnRNPA2 1–189 is composed of two flexible RRM do-
mains
We first used NMR to examine the unbound (apo) form
of the RRMs of hnRNPA2 (residues 1–189). The two-
dimensional 1H–15N heteronuclear single-quantum coher-
ence (HSQC) spectrum of hnRNPA2 1–189 has a wide
chemical shift dispersion, consistent with a folded protein
(Figure 1A). Secondary structure metrics derived from the
observed chemical shifts are consistent with a protein con-
taining both -helices and -sheets (Supplementary Figure
S1A) and the location of these elements are consistent with
the published structure (15). HSQC spectra of the isolated
RRMs (RRM1 1–93, RRM2 94–189) show substantial, but
incomplete, overlap with the HSQC of the tandem RRMs
(hnRNPA2 1–189) (Supplementary Figure S1B). Quantifi-
cation of the chemical shift deviations between the indi-
vidual RRMs and 1–189 show some regions of increased
chemical shift difference, including the N- and C-termini
of both constructs (Figure 1B). There are also some posi-
tions far from the termini, including a contiguous segment
in RRM2 (residues 150–163) where shifts were so large that
we were unable to transfer assignments by overlay. These
chemical shift deviations suggest there may be some signif-
icant interactions between the individual RRMs in 1–189
as was found for hnRNPA1 (16). We mapped the average
chemical shift deviation (Figure 1C, Supplementary Figure
S1C) onto the published crystal structure of the hnRNPA2
RRMs (15) and found that the largest shifts are distributed
throughout the structure, but many localize to the folded
regions of the protein, particularly the helix at the back of
RRM2, suggesting that this region may mediate weak in-
tramolecular interactions (Figure 1C). To test this model,
we performed titrations mixing the individual RRMs and
found larger chemical shifts mixing RRM1 into 15N RRM2
than mixing RRM2 into 15N RRM1 (Supplementary Fig-
ure S1D), suggesting that there may be some weak interac-
tions between the individual RRMs.
We performed NMR spin relaxation experiments R2,
R1 and hetNOE to examine the local reorientational mo-
tions at each backbone position (Figure 1D). Differences
observed in R2 and R1 are due to the decreased size of the
individual RRMs compared to the tandem RRM construct,
but all are consistent with each RRM being a single, folded
domain (Figure 1D). NMR spin relaxation experiments for
1–189 at a second 1H Larmor frequency are largely similar
(Figure 1E). The apparent  c values for apo hnRNPA2 1–
189 at two temperatures are smaller than what is predicted
for a protein of that molecular weight (Table 1), suggest-
ing that the RRM1 and RRM2 can move independently
and are not rigidly confined in the apo state, unlike the
bound state (see below). In contrast, the apparent  c val-
ues for the individual RRMs are in fact larger than what
is predicted for proteins of those molecular weights, con-
sistent with folded domains with disordered tails that slow
tumbling. These findings are in contrast to what was found
for hnRNPA1 individual RRMs and tandem RRMs, which
have much higher  c values (16).
To further probe if RRM1 and RRM2 adopt a rigid ar-
rangement in solution, we performed residual dipolar cou-
pling NMR experiments sensitive to global orientation on
apo hnRNPA2 1–189. Singular value decomposition fitting
of the experimental 1DNH RDCs to the coordinates of the
isolated RRM1 and RRM2 of the 5HO4 crystal structure
of hnRNPA2 bound to RNA (resolution 1.85 Å) (15) yields
RDCs R-factors (24) of 18.8% and 18.9%, respectively (Fig-
ure 1F and Table 2), confirming that the tertiary fold of the
secondary structure elements within RRM1 and RRM2 is
unchanged relative to the crystal structure. When the RDC
data are fit to coordinates of hnRNPA2 1–189 (i.e. RRM1
and RRM2 together), the RDC R-factor increases by more
than 50% (R-factor ∼29.4%, Table 2). These data demon-
strate that, in solution, the relative orientation between the
RRM1 and RRM2 differs from the ones observed in the
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Figure 1. hnRNPA2 RRMs remain folded and interact in the absence of RNA but do not form a rigid structure. See also Supplementary Figure S1. (A)
1H–15N HSQC of hnRNPA2 1–189 is consistent with a folded protein. (B) Chemical shift deviations for the individual RRMs compared to 1–189 are
small and primarily at the N- and C-termini of the constructs (e.g. due only to primary structure differences), except in RRM2 where shifts were too
large to determine peak identity by overlay, as indicated by grey bars. Secondary structure elements as determined by NMR (see Supplementary Figure
S1A) shown at top, -helices in magenta, -sheets in purple. (C) Average chemical shift deviations (plotted in Supplementary Figure S1C) of difference
between individual RRM spectra and tandem RRM spectra mapped on the structure of hnRNPA2 RRMs (PDB: 5HO4) to show where RRM1 and
RRM2 interact with each other in the absence of RNA. (D) NMR spin relaxation parameters 15N R2, 15N R1, and hetNOE values for 1–189 (orange),
RRM1 (1–93 blue), and RRM2 (94–189 green) at 500 MHz 1H frequency indicate the RRM move similarly but have slowed tumbling when the RRMs are
linked. (E) NMR spin relaxation parameters 15N R2, 15N R1 and hetNOE values for 1–189 at 850 MHz 1H frequency (black) and 500 MHz 1H frequency
(orange) indicate the presence of a flexible linker between the individual RRMs. (F) Agreement between the experimental (1DNHobs) RDCs and the back
calculated (1DNHcalc) RDCs from PDB 5HO4 (15) for RRM1 (blue) and RRM2 (green) alone show lower R factors (better agreement) than for the tandem
RRMs together (orange). See Table 2.
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Table 1. Predicted and calculated  c values indicate apo hnRNPA2 1–189 is not rigid
Temperature (◦C) Molecular weight (Da)  c predicted (ns)  c calculated (ns)
Apo hnRNPA2 1–189 37 21 854 9.91 7.95
hnRNPA2 1–189 + rA2RE11 37 25 381 11.49 11.85
Apo hnRNPA2 1–189 25 21 854 13.28 10.57
Apo hnRNPA2 1–93 25 10 785 6.64 7.8
Apo hnRNPA2 94–189 25 11 411 7.01 7.4
Table 2. RDC analysis
Euler angles (◦)a
Number of RDCs φ θ ψ Da (Hz)a ηa R-factor (%)b
RRM1 40 93 78 95 10.6 0.23 18.8
RRM2 31 189 68 94 9.2 0.55 18.9
hnRNPA2 1–189 71 97 82 108 9.1 0.47 29.4
aThe alignment tensor is described by five parameters: three Euler angles (φ, θ and ψ), the magnitude of the alignment tensor Da, and the rhombicity η.
The fact that the values of the alignment tensors of the N- and C-terminal domains are substantially different indicates that their relative orientation is
solution differs from the one observed in the crystal structure of apo hnRNPA2.
bThe RDC R-factor is given by 100 × [〈(Dobs – Dcalc)2〉/(2〈Dobs〉2]1?2, where Dobs and Dcalc are the observed and calculated RDCs, respectively (24).
crystal structure of hnRNPA2 in complex with nucleic acids
(25), which is consistent with NMR relaxation data suggest-
ing fast and at least partially independent rotational diffu-
sion for the structural domains of apo hnRNPA2.
hnRNPA2 RRMs bind the A2RE weakly
As hnRNPA2 is reported to have a high affinity interac-
tion with the A2RE (5), we performed isothermal titration
calorimetry (ITC) with the A2RE. We first performed ITC
on the 11mer RNA (rA2RE11), which is the minimal se-
quence that binds hnRNPA2 (6). With rA2RE11 and hn-
RNPA2 1–189, we found a Kd of about 52 M (Figure 2A),
much weaker than the reported value of about 50 nM (5).
We repeated this experiment at other concentrations of hn-
RNPA2 and A2RE11 and found similarly weak Kd values
(Table 3). Thinking that this low value may be unique to
the buffer conditions used (20 mM NaPi pH 6.75 150 mM
NaCl), we re-did the experiment in a potassium phosphate
buffer at the same pH with no salt and found a similar value
of 35 M (Supplementary Figure S2A). Of note, the calcu-
lated ratio of 1–189 to rA2RE11 for these experiments is
about one to one (Figure 2A, Supplementary Figure S2A,
Table 3), suggesting that one rA2RE11 is capable of bind-
ing the tandem RRMs. To be sure heat of dilution of hn-
RNPA2 1–189 was not altering our results, we performed
ITC diluting hnRNPA2 1–189 into buffer (i.e. no RNA) and
observe nearly no heat signal (Supplementary Figure S2B).
To confirm that we were able to detect tight binding of hn-
RNPA2 1–189 to any RNA sequence, we performed ITC on
the 10mer sequence used by Wu et al. (15). The interaction
between hnRNPA2 1–189 and the Wu 10mer RNA showed
a binding affinity of 228 ± 2 nM (Supplementary Figure
S2C), similar to the reported value and about two orders
of magnitude tighter than any binding affinity we observed
with A2RE, further suggesting that our data showing that
the rA2RE11 interacts weakly with hnRNPA2 1–189 are re-
liable.
Next, we performed ITC with rA2RE21, the full A2RE
present in myelin basic protein mRNA, to determine if
it can bind two copies of hnRNPA2 1–189. At condi-
tions where hnRNPA2 1–189 shows simple 1:1 binding
with rA2RE11, we obtained a biphasic curve when hn-
RNPA2 1–189 binds rA2RE21 (Figure 2B). This curve can-
not be explained by a single binding event and transition
near 2.0 molar ratio indicates that at least two molecules
of hnRNPA2 1–189 are involved. Although the data do not
uniquely specify parameters for a more complicated binding
model, this biphasic curve is consistent with multiple bind-
ing events, indicating that two hnRNPA2 1–189 molecules
are likely able to bind the rA2RE21. To confirm this re-
sult, we repeated the experiment at a different concentration
of rA2RE21 and obtained a similar curve (Supplementary
Figure S2D). We further measured the binding of a scram-
bled rA2RE21, rA2RE21scr, which has the same nucleotide
composition but scrambled sequence, to test the hypothesis
that the rA2RE11 has sequence specificity. We found signa-
tures of significantly reduced binding to rA2RE21scr (Sup-
plementary Figure S2E), demonstrating that although the
hnRNPA2 binding affinities to A2RE RNA are weak, they
are sequence specific.
To understand how binding the shorter A2RE11 affects
hnRNPA2 1–189, we performed an NMR HSQC titration
of the RRMs with increasing amounts of rA2RE11 (Fig-
ure 2C). Some resonances shift and broaden beyond de-
tection at high RNA concentration, some resonances shift
and broaden at intermediate concentrations but partially re-
sharpen at the highest concentrations, and some resonances
appear to shift without significant broadening (Figure 2C).
These observations are suggestive of chemical exchange on
the fast/intermediate chemical shift timescale and are con-
sistent with the weak binding we found using ITC. A large
proportion of the broadening appears to arise from chem-
ical exchange on the intermediate timescale, as peaks that
look to primarily shift also decrease in intensity with addi-
tion of rA2RE11. Chemical shift perturbations (CSPs) tend
to increase with increasing rA2RE11 concentration (Sup-
plementary Figure S3A). Importantly, the chemical shifts
appear to approach saturation at the highest concentration
of rA2RE11 (1:3 protein:RNA where the protein is 200 M
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Figure 2. hnRNPA2 1–189 weakly binds the A2RE RNA. See also Supplementary Figure S2. (A) ITC of the hnRNPA2 1–189 binding to rA2RE11.
Dissociation constant is about 52 M and the interaction stoichiometry is closest to 1 to 1. (B) ITC of hnRNPA2 1–189 binding to rA2RE21. The
isotherm has a distinctive biphasic curve and inflection point at or above 2.0, consistent with multiple binding site scheme (i.e. at least, and most likely, two
hnRNPA2 1–189 can simultaneously bind rA2RE21). (C) 1H–15N HSQC of hnRNPA2 1–189 titrated with increasing concentrations of rA2RE11. Data
is consistent with weak binding with most peaks being in intermediate-fast exchange. Insets show a number of peaks that shift (e.g. T128, F145, V104),
decrease signal intensity (e.g. I132, F54), or shift and decrease then increase signal intensity (e.g. G105, F143). (D) Average chemical shift deviations for
the titration of rA2RE11 (from S3A-B) plotted on PDB structure of hnRNPA2 RRMs 5HO4. (E) Average chemical shift deviations for the titration of
rA2RE21 (from S3D–E) plotted on 5HO4.
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Table 3. Additional 1–189 – rA2RE11 ITC experiments
Syringe: [hnRNPA2 1–189]
(M)
Cell: [rA2RE11]
(M) N Kd (M)
7000 800 0.921 139 ± 10
7000 800 0.798 143 ± 10
4600 115 0.785 19.8 ± 0.4
and the RNA is 600 M), consistent with the ∼50 M dis-
sociation constant and 1:1 binding stoichiometry measured
by ITC. We plotted the 1H–15N weighted average CSPs
(Supplementary Figure S3B) for the highest concertation
of rA2RE11 on the structure of the RRMs and found that
most of the large CSPs are on the second RRM and the
majority of the large (>0.025 ppm) average shifts are on
the -sheet faces of the RRMs (Figure 2D), which is con-
sistent with how hnRNPA2 binds other RNAs (15). Inter-
estingly, the peak intensities broaden and almost none re-
cover to their initial intensity, consistent with a slowing in
the tumbling rate of the molecule upon binding (26).
We also performed a similar titration with rA2RE21 and
found similar increasing CSPs with rA2RE21 concentration
(Supplementary Figure S3C). The peak intensities of 1–189
also tend to broaden then partially recover with increasing
rA2RE21 concentration, although they do not recover to
the same extent as they do with the rA2RE11, likely due
to the larger size of rA2RE21, which further slows tum-
bling (Supplementary Figure S3D). The average CSP for
the titration with rA2RE21 was similar to the ones found
with rA2RE11 (Figures 2E, Supplementary Figure S3E).
No direct evidence of simultaneous binding of two copies
of hnRNPA2 1–189 with the longer rA2RE21 is observed
here, likely because of the weak binding affinity and, at high
RNA concentrations, excess RNA such that each protein
molecule binds a different RNA. As hnRNPA2 binds DNA
as well as RNA, we also performed a titration with a sin-
gle stranded DNA oligomer of the A2RE11 (dA2RE11)
and found that most peaks broaden and did not re-sharpen
at excess dA2RE11 concentrations (Supplementary Figure
S3F), unlike rA2RE11, consistent with even weaker binding
of hnRNPA2 1–189 to DNA than to RNA.
Finally, we performed experiments to determine the
NMR spin relaxation parameters on apo and rA2RE11-
bound hnRNPA2 1–189. The increased 15N R2 and
decreased 15N R1 observed in the 1:3 hnRNPA2 1–
189:rA2RE11 sample compared to the apo sample are in-
dicative of the formation of a higher molecular weight com-
plex, as is expected by binding of the RNA oligomer to 1–
189 (Supplementary Figure S3G). The hetNOE is almost
identical for the bound and apo forms (Supplementary Fig-
ure S3G), suggesting that the local flexibility is not signif-
icantly changed by RNA-binding. Of note, the loop con-
necting RRM1 and RRM2 remains disordered in the RNA-
bound form. However, the global tumbling is different be-
tween the apo and bound forms of hnRNPA2 1–189. In
contrast to the apo RRMs, the hnRNPA2 1–189 bound to
rA2RE11 has an apparent  c consistent with its molecu-
lar weight (Table 1). This observation combined with the
observation that the apo RRMs (hnRNPA2 1–189) have a
smaller  c than predicted suggest that RRM1 and RRM2
are not rigidly confined in the apo state, but they are in the
bound state. Taken together, binding the minimal rA2RE11
locks the RRMs of hnRNPA2 into position and the com-
plete rA2RE21 creates a site for binding two copies of hn-
RNPA2.
hnRNPA2 RRM2 binds calcium
As hnRNPA2 has been reported to bind RNA in a calcium
dependent manner (27), we performed ITC with rA2RE11
in a buffer containing 10 mM calcium. The presence of cal-
cium did not increase the affinity of 1–189 for rA2RE11,
however we observed a biphasic curve for two concentra-
tions of rA2RE11, consistent with multiple binding events
(Figure 3A-B). Finding this result curious, we performed
an NMR titration of hnRNPA2 1–189 and CaCl2, to deter-
mine if hnRNPA2 1–189 is able to bind calcium. Indeed, we
found that approximately residues 110–125 specifically bind
Ca2+ (Figure 3C, D). This suggests a mechanism by which
calcium may alter RNA binding, as part of RRM2 is occu-
pied binding calcium, which may disrupt RNA binding.
Binding of A2RE prevents in vitro phase separation and ag-
gregation of hnRNPA2
As hnRNPA2 can undergo LLPS (10) and RNA has been
shown to alter LLPS of other proteins (28–32), we tested
whether A2RE RNA alters LLPS of hnRNPA2. As there
are two binding sites for hnRNPA2, we hypothesized that
rA2RE21 would increase phase separation of hnRNPA2
by bringing two hnRNPA2 molecules in close proximity
(forming a 2:1 protein:RNA complex), allowing their LCs
to interact and phase separate. In contrast, we expected that
rA2RE11 would not increase LLPS as it only contains one
hnRNPA2 binding site (forming a 1:1 protein:RNA bind-
ing site). However, at all conditions tested (two salt concen-
trations, four ratios of protein to RNA, both length RNA
oligomers), addition of either rA2RE11 or rA2RE21 pre-
vented LLPS of full-length hnRNPA2 WT (Supplemen-
tary Figure S4A-C). We saw no evidence that addition of
RNA simply delayed formation of visible droplets, as no
hnRNPA2 droplets were observed in the presence of RNA
at any time tested, up to two hours, though droplets were
observed at all time points tested in the absence of RNA
(Figure 4A). Although weak multivalent interactions are
known to contribute to LLPS (21), it is important to note
that, given the relatively weak affinities for the A2RE with
hnRNPA2 1–189 (i.e. the LLPS assay is performed at con-
centrations below the dissociation constant), a majority of
the RNA is not predicted to bind two copies of the protein
simultaneously, perhaps contributing to the lack of stimula-
tion of LLPS by addition of rA2RE21. Here, we performed
all LLPS assays at 15 M hnRNPA2 FL as hnRNPA2 FL
undergoes robust LLPS at that concentration (10,33). De-
spite the fact that at these concentrations (given the binding
affinities we found for rA2RE11 and rA2RE21) only a frac-
tion of hnRNPA2 RRMs would be expected to bind RNA,
we do see a profound disruption of LLPS by addition of
RNA on LLPS. Of note, it is unclear what the ratio of RNA
to protein molecules is in granules in cells, so it is possible
that there is an even greater ratio of protein:RNA in those
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Figure 3. hnRNPA2 RRM2 binds calcium ions. (A) ITC of the RRMs binding to rA2RE11 in the presence of calcium. The isotherm has a biphasic curve
consistent with multiple binding, indicating that the presence of calcium is altering the binding of the RRMs to the RNA, although the apparent binding
affinity does not increase. (Note that the small peaks in the beginning of the thermogram were caused by a series of 5 small (2 l) injections to ensure
reliable data for the first large injection used for isotherm quantification). (B) ITC of the RRMs binding to rA2RE11 in the presence of calcium at half the
concentration of RNA. The isotherm still has a biphasic curve consistent with multiple binding events, indicating that the presence of calcium is altering
the binding of the RRMs to the RNA. (C) Chemical shift deviation of hnRNPA2 RRMs with 5 or 10 mM CaCl2 added. Chemical shift deviations indicate
the presence of a binding pocket for calcium in the second RRM around residues 110–125. Vertical grey bars indicate histidine residues, showing that the
shifts are not localized to histidine positions and therefore unlikely to be due to possible slight deviations in pH. (D) Average CSPs for the 10 mM CaCl2
condition plotted onto 5HO4 suggest that Ca2+ primarily binds a single helix at the back of RRM2.
granules, which may explain how granules maintain their
integrity in cells.
To further understand this surprising finding, we per-
formed similar experiments on additional RNA sequences.
First, we asked if the LC of hnRNPA2 can directly inter-
act with RNA and hence contribute to the inhibition of
LLPS. To this end, we obtained a Cy-3 labeled rA2RE11
and mixed it at varying ratios with hnRNPA2 LC at con-
ditions where hnRNPA2 LC undergoes LLPS (10). Indeed,
we found that this Cy-3 labeled rA2RE11 avidly partitions
into hnRNPA2 LC droplets (Supplementary Figure S4D).
As such, we hypothesized that a longer RNA may stimu-
late hnRNPA2 full-length LLPS in our original assay as
both the RRMs and LC could simultaneously interact with
RNA. We obtained two 60-mer RNAs, one containing the
A2RE21 sequence flanked by myelin basic protein mRNA
sequence (long rA2RE21) and one with the same flank-
ing sequence but the scrambled A2RE (long rA2RE21scr)
that does not specifically bind the RRMs (see Supplemen-
tary Figure S2E), and performed LLPS assays with hn-
RNPA2 FL. In contrast to our hypothesis, we once again
observed no LLPS in the presence of any RNA concen-
tration for both 60mers (Supplementary Figure S4E). Fur-
ther, the rA2RE21scr alone also eliminates LLPS of hn-
RNPA2 (Supplementary Figure S4F), suggesting that the
effect observed is not due to binding the RRMs with se-
quence specificity. Finally, we tested whether the tight-
binding Wu 10mer RNA altered LLPS of hnRNPA2 FL.
In contrast to all other RNAs tested, the Wu 10mer RNA
did not eliminate LLPS of hnRNPA2 FL at low concentra-
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Figure 4. rA2RE11 and rA2RE21 prevent phase separation and aggregation of full-length hnRNPA2 WT and mutants. See also Supplementary Figure
S4. (A) After cleavage of a C-terminal maltose binding protein solubility tag by TEV protease, hnRNPA2 FL WT undergoes LLPS. In the presence of
either rA2RE11 or rA2RE21, hnRNPA2 FL WT does not undergo LLPS. (B, C) After cleavage of a C-terminal maltose binding protein solubility tag by
TEV protease, hnRNPA2 FL D290V (B) and P298L (C) undergo LLPS followed by aggregation. In the presence of either rA2RE11 or rA2RE21, neither
phase separation nor aggregation occur.
tions (1:0.25 and 1:0.5 protein:RNA ratios) but does sup-
press LLPS at 1:1 ratio and above (Supplementary Figure
S4G). As such, it seems that at these conditions the LC do-
main of hnRNPA2 mediates contacts leading to LLPS in
the absence of RNA but competes with the RRMs for RNA
binding, suggesting that RNA interaction with hnRNPA2
LC is important for altering in vitro LLPS.
After observing the complete elimination of LLPS of hn-
RNPA2 at all rA2RE11 or 21 concentrations tested, we hy-
pothesized that addition of RNA would also prevent aggre-
gation of the hnRNPA2 disease-associated mutants, D290V
and P298L. Indeed, while both D290V and P298L formed
aggregates over time, the addition of RNA prevented for-
mation of both liquid droplets and solid aggregates at these
conditions (Figure 4B, C). This prevention of aggregation
was even greater than that exerted by partial tyrosine phos-
phorylation (33), as here neither D290V nor P298L showed
any droplets in the presence of RNA.
DISCUSSION
Here, we examine the structural basis for the interaction
between the hnRNPA2 RRMs (1–189) and the A2RE of
myelin basic protein mRNA. In contrast to previous re-
ports (5), we find that both the 11mer and 21mer RNA
oligomers bind to hnRNPA2 1–189 weakly (Figure 5), with
a binding affinity on the order of tens of micromolar. Given
that we have recently shown hnRNPA2 is highly prone to
phase separate and aggregate and requires careful use of sol-
ubility tags and RNA removal to prevent pre-aggregation
(10,22,30,33), it is possible that self-interactions between
full-length hnRNPA2 molecules (e.g. pre-formed aggre-
gates) and protein-surface interactions complicated previ-
ous bio-sensor measurements performed with full-length re-
combinant protein. We did not observe a significant differ-
ence in binding affinity in the presence of calcium or using a
potassium phosphate buffer without sodium chloride, sug-
gesting that for this construct and the A2RE RNA, the in-
teraction is not primarily electrostatic. Indeed, recognition
of the bases, not the phosphodiester backbone, is the com-
mon mechanism for RRM-RNA interaction (34). Impor-
tantly, we can recapitulate tighter binding of our hnRNPA2
construct with a different RNA previously shown to inter-
act with hnRNPA2 (15). We also observed a weaker though
comparable interaction with DNA oligos, suggesting that
hnRNPA2 may interact with both RNA and DNA in cells;
hnRNPA2 is known to be involved in the maintenance of
telomeres (35). The regions of hnRNPA2 observed to inter-
act with RNA in the crystal structure are consistent with the
chemical shifts observed with RNA in our NMR studies.
In contrast to the published crystal structure of hnRNPA2
bound to other RNA sequences (15), the interaction be-
tween 1 and 189 and rA2RE11 requires only one molecule
of hnRNPA2 and one molecule of rA2RE11, suggesting the
observation that the individual RRMs of a single hnRNPA2
molecule bind to separate RNA molecules is not the case
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Figure 5. Model. Apo hnRNPA2 1–189 has some conformational flexibility in the orientation of the two RRM domains relative to one another. hnRNPA2
1–189 can bind one rA2RE11 molecule, which locks the relative orientation of the RRMs, while more than one molecule of hnRNPA2 1–189 can bind
one rA2RE21. The LC of hnRNPA2 competes with the RRMs for interaction with RNA, preventing LC–LC interactions critical for LLPS. Addition of
RNA prevent LLPS of full length hnRNPA2 and aggregation of disease mutant hnRNPA2 by binding to the LC domain.
for the A2RE11 and may be a crystal artifact (14). Further-
more, we saw no evidence for a significant change in the ap-
parent dissociation constant at different concentrations of
RNA (the fixed concentration in the ITC cell) which would
be expected for a two RNA to two protein binding mode.
Hence, these findings highlight the importance of solution-
state experiments for fully understanding binding modes.
In contrast to our hypothesis, we observed that addition
of either rA2RE11 or rA2RE21 completely abolished the
ability of full length hnRNPA2 to undergo LLPS, while we
expected the 21mer to stimulate LLPS as the RNA is mul-
tivalent (Figure 5). This elimination of LLPS may be for
a few reasons. First, full length hnRNPA2 is more soluble
in higher salt conditions (as evidenced by Supplementary
Figure S4C and our purification conditions of 1 M NaCl).
RNA is a highly charged molecule and adding a short RNA
may have a similar effect as increasing the salt concentra-
tion of the sample. Second, the low complexity (LC) do-
main of hnRNPA2 has multiple RGG motifs, which have
been shown to interact with RNA in other proteins (36–
38) and the LC interacts with A2RE11 RNA in a liquid-
like phase. It seems that any LC–RNA interactions in the
context of the full-length protein contribute to elimination
of LLPS, suggesting that LC-LC interactions are crucial
for maintaining the integrity of the droplets. Interestingly,
other groups have found that short RNAs do not stimulate
phase separation of G3BP1 while longer RNAs do (12,13),
suggesting that RNA length plays a larger role in provid-
ing multivalency than we expected. However, with 60-mer
RNA oligomers, we still observed no LLPS, suggesting the
protein-protein interactions are more important for LLPS
than RNA-protein interactions for hnRNPA2 at these con-
ditions. The impact of physiological arginine methylation,
which alters hnRNPA2 LC self-interaction and LLPS (10),
on hnRNPA2 LC interactions with RNA will be important
to study in the future. Though our focus here is on the RNA-
binding properties of the hnRNPA2 RRMs to the A2RE, it
is possible that the in vitro LLPS experiments may not rep-
resent the effect of RNA on hnRNPA2 phase separation in
cells where other protein and RNA interactions may coop-
erate with the A2RE interaction with hnRNPA2 RRMs to
stabilize a granule (33).
We also observed that aggregation of mutant full-length
hnRNPA2 was abolished upon addition of RNA. Inter-
estingly, this finding parallels work showing that RNA is
excluded from TDP-43 inclusions in cells and that total
HEK298 cell RNA reduced TDP-43 phase separation and
aggregation in vitro (39). Further, reduction of TDP-43 as-
sembly in neurons by short oligonucleotides (34 nucleotides
long) prevented neurotoxicity (39), suggesting that the same
may be true for hnRNPA2. hnRNPA2 is also a component
of transport granules, membraneless organelles that move
mRNAs from the perinucleus to sites of local translation
(2). While these granules are hypothesized to be phase sep-
arated (21,33), that has not yet been tested in cells. How-
ever, transport granules contain multiple components be-
sides RNA and hnRNPA2 that may contribute to the mul-
tivalent interactions required for LLPS.
DATA AVAILABILITY
NMR chemical shift assignments for hnRNPA2 1–189 at
298 K (BMRB: 50254), 310 K (BMRB: 50255) and bound
hnRNPA2 1–189 at 310 K (BMRB: 50257) can be obtained
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online from the Biological Magnetic Resonance Database
(BMRB, http://www.bmrb.wisc.edu/). Plasmids generated
herein can be found at Addgene.org.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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